Medicine
Intralipid 25 g/250 mL injectable emulsion
Intralipid 25 g/250 mL injectable emulsion is a prescription medicine containing Soybean oil for intravenous use, marketed by Baxter Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze Intralipid 10%. Intralipid 10% should not be stored above 25°C…
Key facts
- Active ingredient (INN)
- Soybean oil
- Brand
- Intralipid
- Strength
- 25 g/250 mL
- Dosage form
- Injectable emulsion
- Route
- Intravenous
- Packs
- 250 mL
- Marketing authorisation holder
- Baxter Healthcare
- Manufacturer
- Baxter Healthcare
- Origin register
- US FDA, United States
- Storage
- Do not freeze Intralipid 10%. Intralipid 10% should not be stored above 25°C (77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 December 2014
- Identifiers
- RxCUI 1859368, 1859370, 1859372 +3DailyMed set ID 069460a5-3e9a-428f-b2dc-3405690f4fd7NDC 0338-0518Application NDA017643
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 250 mL in 1 bag | 0338-0518-12 | Baxter Healthcare | 12 December 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 October 1975 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Soybean oil
Clinical summary
Soybean oil is a lipid emulsion. It is available as injectable emulsion and injection for intravenous use. MedsAcross supplies Soybean oil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Soybean oilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Intralipid prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Intralipid 25 g/250 mL injectable emulsion for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.